The Emerging Role of M6A and Programmed Cell Death in Cardiovascular Diseases

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2025 Feb 26

PMID 40001550

Authors

Haixia Wang

Juanjuan Han

Hui Kong

Ce Ma

Xin-An Zhang

Affiliations

Soon will be listed here.

Abstract

N6-methyladenosine (m6A) is the most prevalent internal chemical modification in eukaryotic messenger RNA (mRNA), significantly impacting its lifecycle through dynamic and reversible processes involving methyltransferase, demethylase, and binding proteins. These processes regulate mRNA stability, splicing, nuclear export, translation, and degradation. Programmed cell death (PCD), a tightly controlled process encompassing apoptosis, pyroptosis, ferroptosis, autophagy, and necroptosis, plays a crucial role in maintaining cellular homeostasis, tissue development, and function. Recently, m6A modification has emerged as a significant research area due to its role in regulating PCD and its implications in cardiovascular diseases (CVDs). In this review, we delve into the intricate relationship between various PCD types and m6A modification, emphasizing their pivotal roles in the initiation and progression of CVDs such as myocardial ischemia-reperfusion (I/R), atherosclerosis (AS), pulmonary hypertension (PH), cardiomyopathy, doxorubicin (Dox)-induced cardiotoxicity (DIC), heart failure (HF), and myocardial infarction (MI). Our findings underscore the potential of elucidating the roles of m6A and PCD in CVD to pave new pathways for prevention and treatment strategies.

References

Zhang H, Wu D, Wang Y, Guo K, Spencer C, Ortoga L . METTL3-mediated N6-methyladenosine exacerbates ferroptosis via m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming in sepsis-induced acute lung injury. Clin Transl Med. 2023; 13(9):e1389. PMC: 10504453. DOI: 10.1002/ctm2.1389. View

Chen K, Lu Z, Wang X, Fu Y, Luo G, Liu N . High-resolution N(6) -methyladenosine (m(6) A) map using photo-crosslinking-assisted m(6) A sequencing. Angew Chem Int Ed Engl. 2014; 54(5):1587-90. PMC: 4396828. DOI: 10.1002/anie.201410647. View

Zhou Q, Tian M, Cao Y, Tang M, Xiang X, Guo L . YTHDC1 aggravates high glucose-induced retinal vascular endothelial cell injury via m6A modification of CDK6. Biol Direct. 2024; 19(1):54. PMC: 11229198. DOI: 10.1186/s13062-024-00498-7. View

Zhang B, Han L, Tang Y, Zhang G, Fan X, Zhang J . METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion. Eur Rev Med Pharmacol Sci. 2020; 24(12):7015-7023. DOI: 10.26355/eurrev_202006_21694. View

Hu L, Yu Y, Shen Y, Huang H, Lin D, Wang K . Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages. Redox Biol. 2023; 61:102638. PMC: 9975317. DOI: 10.1016/j.redox.2023.102638. View

Xu Y, Yuan X, Wu J, Chen R, Xia L, Zhang M . The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1. J Cell Biochem. 2019; 121(1):524-533. DOI: 10.1002/jcb.29258. View

Xu Y, Ye S, Zhang N, Zheng S, Liu H, Zhou K . The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer. Cancer Commun (Lond). 2020; 40(10):484-500. PMC: 7571404. DOI: 10.1002/cac2.12075. View

Hao W, Dian M, Zhou Y, Zhong Q, Pang W, Li Z . Autophagy induction promoted by mA reader YTHDF3 through translation upregulation of FOXO3 mRNA. Nat Commun. 2022; 13(1):5845. PMC: 9532426. DOI: 10.1038/s41467-022-32963-0. View

Savarese G, Lund L . Global Public Health Burden of Heart Failure. Card Fail Rev. 2017; 3(1):7-11. PMC: 5494150. DOI: 10.15420/cfr.2016:25:2. View

10.

Yang Y, Ren J, Zhang J, Shi H, Wang J, Yan Y . FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner. Redox Biol. 2024; 70:103067. PMC: 10862061. DOI: 10.1016/j.redox.2024.103067. View

11.

Chen X, Gong W, Shao X, Shi T, Zhang L, Dong J . METTL3-mediated mA modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression. Ann Rheum Dis. 2021; 81(1):87-99. DOI: 10.1136/annrheumdis-2021-221091. View

12.

Wang P, Doxtader K, Nam Y . Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol Cell. 2016; 63(2):306-317. PMC: 4958592. DOI: 10.1016/j.molcel.2016.05.041. View

13.

Wang J, Shen Y, Zhang Y, Lin D, Wang Q, Sun X . Smooth Muscle Ythdf2 Abrogation Ameliorates Pulmonary Vascular Remodeling by Regulating Myadm Transcript Stability. Hypertension. 2024; 81(8):1785-1798. DOI: 10.1161/HYPERTENSIONAHA.124.22801. View

14.

Shi W, Chen R, Zhou M, Li Y, Zhang Y, Wang J . Methyltransferase METTL3 governs the modulation of SH3BGR expression through m6A methylation modification, imparting influence on apoptosis in the context of Down syndrome-associated cardiac development. Cell Death Discov. 2024; 10(1):396. PMC: 11377721. DOI: 10.1038/s41420-024-02164-3. View

15.

Xu S, Ilyas I, Little P, Li H, Kamato D, Zheng X . Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev. 2021; 73(3):924-967. DOI: 10.1124/pharmrev.120.000096. View

16.

Wang X, Li S, Song H, Ding Y, Gao R, Shi X . METTL14-upregulated miR-6858 triggers cell apoptosis in keratinocytes of oral lichen planus through decreasing GSDMC. Commun Biol. 2023; 6(1):976. PMC: 10517968. DOI: 10.1038/s42003-023-05360-6. View

17.

Falnes P, Klungland A, Alseth I . Repair of methyl lesions in DNA and RNA by oxidative demethylation. Neuroscience. 2006; 145(4):1222-32. DOI: 10.1016/j.neuroscience.2006.11.018. View

18.

Xia H, Wu Y, Zhao J, Cheng C, Lin J, Yang Y . N6-Methyladenosine-modified circSAV1 triggers ferroptosis in COPD through recruiting YTHDF1 to facilitate the translation of IREB2. Cell Death Differ. 2023; 30(5):1293-1304. PMC: 10154389. DOI: 10.1038/s41418-023-01138-9. View

19.

Wang F, Sun Z, Zhang Q, Yang H, Yang G, Yang Q . Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer. Chin Med. 2023; 18(1):122. PMC: 10512537. DOI: 10.1186/s13020-023-00820-x. View

20.

Wu L, Du Y, Wang L, Zhang Y, Ren J . Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis. Redox Biol. 2024; 72:103157. PMC: 11033199. DOI: 10.1016/j.redox.2024.103157. View